Intrapulmonary-administered myeloid derived suppressor cells rescue mice from Pseudomonas aeruginosa infection and promote a regulatory/repair phenotype. Maëlys Born-Bony
Mucosal Immunol. 2025 Mar 17:S1933-0219(25)00027-3. doi: 10.1016/j.mucimm.2025.03.001. Online ahead of print. ABSTRACT Pseudomonas aeruginosa (P.aeruginosa) is a pathogenic opportunistic bacterium, classified as a priority by the WHO for the research of new treatments. As this bacterium is harmful through the inflammation and tissue damage it causes, we investigated the role of Myeloid Derived Suppressor Cells … Read more